Syngene Acquires US Biologics Facility for $36.5M
- Syngene International has acquired its first biologics facility in the US from Emergent Manufacturing Operations Baltimore for $36.5 million.
- The acquisition will increase Syngene’s single-use bioreactor capacity to 50,000 liters, en...